Patents
Literature
4 results about "Pervasive developmental disorder" patented technology
Efficacy Topic
Property
Owner
Technical Advancement
Application Domain
Technology Topic
Technology Field Word
Patent Country/Region
Patent Type
Patent Status
Application Year
Inventor
The diagnostic category pervasive developmental disorders (PDD), as opposed to specific developmental disorders (SDD), is a group of five disorders characterized by delays in the development of multiple basic functions including socialization and communication. The pervasive developmental disorders are autism, Asperger syndrome, pervasive developmental disorder not otherwise specified (all autism spectrum disorders) and Rett syndrome.
Methods of treating diseases
In one embodiment of the present invention, the present invention relates to a pharmaceutical composition for treating an individual having a disorder selected from communication disorders, motor impairments, cognitive impairments, mental disorders, sensory disorders, autism spectrum disorders, and pervasive developmental disorders, the pharmaceutical composition comprising L-serine or a pharmaceutically acceptable salt thereof.
Owner:ASTROGEN CO LTD
Treatment of autism spectrum disorder and associated neuroinflammation using fibroblasts and derivatives thereof
PendingJP2025084858ANervous disorderUnknown materialsPervasive developmental disorderWhite blood cell
To provide methods and compositions useful for treatment of pervasive developmental disorders.SOLUTION: The treatment includes the use of fibroblasts, modified fibroblasts, and derivatives thereof for reduction of neuroinflammation and / or gastrointestinal inflammation in a patient in need of treatment, such as having a pervasive developmental disorder. Fibroblasts, modified fibroblasts, and derivatives thereof may be administered at a frequency and concentration sufficient to reduce interleukin-17 production in the gut of patients with autism spectrum disorder.SELECTED DRAWING: Figure 1
Owner:SPINALCYTE LLC
Method for treating a disorder
ActiveUS20250152538A1Organic active ingredientsNervous disorderDiseasePervasive developmental disorder
A method of treating an individual having a disease selected from communication disorder, abnormal motor ability, cognitive disorder, mental disorder, sensory disturbance, autism spectrum disorder, and pervasive developmental disorder is disclosed. The method includes administering L-serine or a pharmaceutically acceptable salt thereof or a pharmaceutical composition containing L-serine or a pharmaceutically acceptable salt thereof to an individual having the disease.
Owner:ASTROGEN CO LTD
Method for treating a disorder
A method of treating an individual having a disease selected from communication disorder, abnormal motor ability, cognitive disorder, mental disorder, sensory disturbance, autism spectrum disorder, and pervasive developmental disorder is disclosed. The method includes administering L-serine or a pharmaceutically acceptable salt thereof or a pharmaceutical composition containing L-serine or a pharmaceutically acceptable salt thereof to an individual having the disease.
Owner:ASTROGEN INC